ENLVon logo

Enlivex Therapeutics Ltd (ENLV)

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
ENLV
ISIN Code
IL0011319527
Currency
US Dollar (USD)
IPO Date
1995-12-12

Contact Information

Company Address
14 Einstein Street, Ness Ziona, Israel, 7403618
Contact Phone
972 2 620 8072
Company Website
https://www.enlivex.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$0
Return on Assets (TTM)
-0.80%
EBITDA
$-999,999.99
Revenue (TTM)
$0